- Home
- IBRX vs SWX Comparison
IBRX vs SWX Comparison
Compare IBRX & SWX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IBRX | SWX |
|---|---|---|
| Founded | 2014 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 6.7B |
| IPO Year | 2015 | 2017 |
Fundamental Metrics
Financial Performance| Metric | IBRX | SWX |
|---|---|---|
| Price | $7.54 | $93.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $12.57 | ★ $87.40 |
| AVG Volume (30 Days) | ★ 12.2M | 537.5K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.70% |
| EPS Growth | 38.71 | ★ 120.29 |
| EPS | N/A | ★ 1.91 |
| Revenue | $113,288,000.00 | ★ $5,433,972,000.00 |
| Revenue This Year | $88.59 | $18.48 |
| Revenue Next Year | $131.15 | $2.61 |
| P/E Ratio | ★ N/A | $48.21 |
| Revenue Growth | ★ 668.31 | 9.56 |
| 52 Week Low | $1.95 | $75.75 |
| 52 Week High | $12.43 | $94.47 |
Technical Indicators
Market Signals| Indicator | IBRX | SWX |
|---|---|---|
| Relative Strength Index (RSI) | 44.85 | 61.98 |
| Support Level | $6.69 | $87.41 |
| Resistance Level | $8.54 | $93.93 |
| Average True Range (ATR) | 0.54 | 1.55 |
| MACD | -0.12 | 0.17 |
| Stochastic Oscillator | 12.61 | 79.15 |
Price Performance
Historical ComparisonAbout IBRX ImmunityBio Inc.
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
About SWX Southwest Gas Holdings Inc. (DE)
Southwest Gas Holdings Inc is a utility company engaged in the purchasing, distributing, and transporting of natural gas in the American Southwest. The company segments its activities into natural gas distribution segment. The Natural gas distribution segment encompasses the company's core natural gas business as distributors in the states of Arizona and Nevada. Its division is responsible for roughly half of Southwest Gas' total revenue through the sale of natural gas to mainly residential and small commercial customers.